{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:51:48Z","timestamp":1781621508830,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous studies have reported excellent disease control and survival in patients with well-lateralized, American Joint Committee on Cancer (AJCC)-7 T1-2N2b\u00a0tonsillar squamous cell carcinoma (SCC). The reduced treatment volume is associated with lower rates of physician-assessed toxicity. Patient-reported outcomes (PROs) have been proposed as a similarly reliable measure, but the body of literature is limited for unilaterally treated patients. Our goal was to review PROs of such patients who had reduced treatment volumes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed PROs of patients with AJCC-7 T1-2N2b disease treated with ipsilateral radiation therapy (RT), with or without surgery or chemotherapy before RT. PROs were measured using the MD Anderson Symptom Inventory for head and neck cancer after a median of 28.9\u00a0months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty-eight patients were included in the study: 36 (75%) had human papillomavirus-positive disease, 20 (42%) had\u2009\u2265\u20092 nodal levels involved, 15 (31%) had extranodal extension and all patients had N2b disease. Most patients reported no symptoms; a median 72.9% for all 10 head-and-neck symptoms, 75.0% for all 12 core symptoms, and 83.3% for all 6 interference symptoms reported a score of \u201c0\u201d. The most common head-and-neck and core symptoms were dry mouth (n\u2009=\u200933, 69%) and fatigue (n\u2009=\u200923, 48%). Treatment mostly interfered with general activities. PROs were not affected by receipt of surgery; however, receipt of systemic therapy was associated with worse general activity (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.044). Longitudinal analyses revealed mildly worse dry mouth (from 0 of 10 points to 1.5 of 10,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012) and numbness\/tingling (from 0 of 10 to 0.5 of 10,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.020).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ipsilateral neck RT for N2b tonsil SCC was associated with only a mild PRO symptom burden after at least 18\u00a0months, and therefore, a well-tolerated toxicity reduction strategy for appropriate patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12672-025-03896-z","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:10:41Z","timestamp":1764072641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-reported outcomes after ipsilateral radiation therapy for N2b tonsillar squamous cell carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Chike O.","family":"Abana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Garden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Brandon Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Chronowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah S. R.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Frankart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Bahig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly E. A.","family":"Barbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Hutcheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Takiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton D.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"12","key":"3896_CR1","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/cncr.29262","volume":"121","author":"CB O'Neill","year":"2015","unstructured":"O\u2019Neill CB, Baxi SS, Atoria CL, O\u2019Neill JP, Henman MC, Sherman EJ, et al. Treatment-related toxicities in older adults with head and neck cancer: a population-based analysis. Cancer. 2015;121(12):2083\u20139.","journal-title":"Cancer"},{"issue":"11","key":"3896_CR2","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/cncr.22302","volume":"107","author":"P Dirix","year":"2006","unstructured":"Dirix P, Nuyts S, Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer. 2006;107(11):2525\u201334.","journal-title":"Cancer"},{"issue":"2","key":"3896_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijrobp.2007.01.024","volume":"68","author":"BA Jereczek-Fossa","year":"2007","unstructured":"Jereczek-Fossa BA, Santoro L, Alterio D, Franchi B, Fiore MR, Fossati P, et al. Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys. 2007;68(2):403\u201315.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"3896_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/14737140.7.7.1043","volume":"7","author":"BA Murphy","year":"2007","unstructured":"Murphy BA, Gilbert J, Ridner SH. Systemic and global toxicities of head and neck treatment. Expert Rev Anticancer Ther. 2007;7(7):1043\u201353.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"22","key":"3896_CR5","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","volume":"26","author":"JA Langendijk","year":"2008","unstructured":"Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol. 2008;26(22):3770\u20136.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3896_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","volume":"112","author":"MB Barton","year":"2014","unstructured":"Barton MB, Jacob S, Shafiq J, Wong K, Thompson SR, Hanna TP, et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol. 2014;112(1):140\u20134.","journal-title":"Radiother Oncol"},{"issue":"1","key":"3896_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.radonc.2015.07.042","volume":"117","author":"ME Christianen","year":"2015","unstructured":"Christianen ME, Verdonck-de Leeuw IM, Doornaert P, Chouvalova O, Steenbakkers RJ, Koken PW, et al. Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation. Radiother Oncol. 2015;117(1):139\u201344.","journal-title":"Radiother Oncol"},{"issue":"10","key":"3896_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/hed.20602","volume":"29","author":"DI Rosenthal","year":"2007","unstructured":"Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007;29(10):923\u201331.","journal-title":"Head Neck"},{"issue":"1","key":"3896_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.radonc.2017.10.037","volume":"126","author":"M Kamal","year":"2018","unstructured":"Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, et al. Patient reported dry mouth: instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol. 2018;126(1):75\u201380.","journal-title":"Radiother Oncol"},{"issue":"1","key":"3896_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.radonc.2015.09.007","volume":"117","author":"GB Gunn","year":"2015","unstructured":"Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, et al. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: results from a symptom assessment study. Radiother Oncol. 2015;117(1):132\u20138.","journal-title":"Radiother Oncol"},{"issue":"1","key":"3896_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13014-017-0878-9","volume":"12","author":"SA Eraj","year":"2017","unstructured":"Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, et al. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients >\/=65 years old. Radiat Oncol. 2017;12(1):150.","journal-title":"Radiat Oncol"},{"issue":"13","key":"3896_CR12","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1002\/cncr.28672","volume":"120","author":"DI Rosenthal","year":"2014","unstructured":"Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, et al. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center symptom inventory-head and neck module. Cancer. 2014;120(13):1975\u201384.","journal-title":"Cancer"},{"issue":"2","key":"3896_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2015.12.008","volume":"118","author":"PB Romesser","year":"2016","unstructured":"Romesser PB, Cahlon O, Scher E, Zhou Y, Berry SL, Rybkin A, et al. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol. 2016;118(2):286\u201392.","journal-title":"Radiother Oncol"},{"issue":"9","key":"3896_CR14","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1200\/JCO.20.03128","volume":"39","author":"SS Yom","year":"2021","unstructured":"Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, et al. Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG oncology HN002). J Clin Oncol. 2021;39(9):956\u201365.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3896_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","volume":"12","author":"CM Nutting","year":"2011","unstructured":"Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127\u201336.","journal-title":"Lancet Oncol"},{"key":"3896_CR16","unstructured":"Yom SS. De-intensified radiation therapy with chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in treating patients with early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer. ClinicalTrialsgov Identifier: NCT03952585."},{"issue":"23","key":"3896_CR17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.21037\/atm-20-2984","volume":"8","author":"MP Strohl","year":"2020","unstructured":"Strohl MP, Wai KC, Ha PK. De-intensification strategies in HPV-related oropharyngeal squamous cell carcinoma-a narrative review. Ann Transl Med. 2020;8(23):1601.","journal-title":"Ann Transl Med"},{"issue":"22","key":"3896_CR18","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1200\/JCO.20.00056","volume":"38","author":"H Mehanna","year":"2020","unstructured":"Mehanna H, Rischin D, Wong SJ, Gregoire V, Ferris R, Waldron J, et al. De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer intergroup framework for future de-escalation studies. J Clin Oncol. 2020;38(22):2552\u20137.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3896_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.55209","volume":"6","author":"NB Razavian","year":"2023","unstructured":"Razavian NB, D\u2019Agostino RB Jr, Steber CR, Helis CA, Hughes RT. Association of unilateral radiotherapy with contralateral lymph node failure among patients with squamous cell carcinoma of the tonsil: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(2):e2255209.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3896_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijrobp.2011.06.1975","volume":"83","author":"GM Chronowski","year":"2012","unstructured":"Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, et al. Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):204\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"3896_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/COC.0000000000000940","volume":"45","author":"AJ Frankart","year":"2022","unstructured":"Frankart AJ, Abana CO, Geier N, Bahig H, Manzar GS, Garden AS, et al. Long-term locoregional control with unilateral radiation for AJCC-7 T1\u20132N2b tonsillar cancer. Am J Clin Oncol. 2022;45(10):422\u20136.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"3896_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.ijrobp.2012.08.004","volume":"85","author":"AS Garden","year":"2013","unstructured":"Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, et al. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(4):941\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"3896_CR23","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1002\/cncr.28831","volume":"120","author":"AS Garden","year":"2014","unstructured":"Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, et al. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer. 2014;120(19):3082\u20138.","journal-title":"Cancer"},{"key":"3896_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1748-717X-8-21","volume":"8","author":"AS Garden","year":"2013","unstructured":"Garden AS, Kies MS, Morrison WH, Weber RS, Frank SJ, Glisson BS, et al. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol. 2013;8:21.","journal-title":"Radiat Oncol"},{"issue":"5","key":"3896_CR25","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.ijrobp.2008.02.072","volume":"72","author":"DI Rosenthal","year":"2008","unstructured":"Rosenthal DI, Mendoza TR, Chambers MS, Burkett VS, Garden AS, Hessell AC, et al. The M. D. anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008;72(5):1355\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3896_CR26","doi-asserted-by":"crossref","unstructured":"Vigano A, De Felice F, Iacovelli NA, Alterio D, Facchinetti N, Oneta O, et al. M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy +\/\u2212 systemic therapy\u2014a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Oral Oncol. 2021;115:105189.","DOI":"10.1016\/j.oraloncology.2021.105189"},{"key":"3896_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.radonc.2020.05.007","volume":"148","author":"D Pasalic","year":"2020","unstructured":"Pasalic D, Ludmir EB, Allen PK, Thaker NG, Chapman BV, Hanna EY, et al. Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy. Radiother Oncol. 2020;148:258\u201366.","journal-title":"Radiother Oncol"},{"issue":"21","key":"3896_CR28","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1200\/JCO.2010.32.2453","volume":"29","author":"EE Takeuchi","year":"2011","unstructured":"Takeuchi EE, Keding A, Awad N, Hofmann U, Campbell LJ, Selby PJ, et al. Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. J Clin Oncol. 2011;29(21):2910\u20137.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3896_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jval.2020.10.017","volume":"24","author":"F Efficace","year":"2021","unstructured":"Efficace F, Collins GS, Cottone F, Giesinger JM, Sommer K, Anota A, et al. Patient-reported outcomes as independent prognostic factors for survival in oncology: systematic review and meta-analysis. Value Health. 2021;24(2):250\u201367.","journal-title":"Value Health"},{"key":"3896_CR30","doi-asserted-by":"crossref","unstructured":"McDowell L, Rischin D, King M, Kenny L, Porceddu S, Wratten C, et al. Patient- and clinician-reported outcomes in human papillomavirus-associated tonsillar carcinoma treated with unilateral and bilateral intensity modulated radiation therapy-A substudy from TROG12.01. Int J Radiat Oncol Biol Phys. 2022.","DOI":"10.1016\/j.ijrobp.2022.08.006"},{"issue":"6","key":"3896_CR31","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/lio2.487","volume":"5","author":"FE Mott","year":"2020","unstructured":"Mott FE, Sacks R, Johnson F, Hutcheson KA, Gallagher N, Varghese S, et al. Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI). Laryngoscope Investig Otolaryngol. 2020;5(6):1104\u20139.","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"3","key":"3896_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/01945998211059967","volume":"167","author":"CEA Barbon","year":"2022","unstructured":"Barbon CEA, Yao CMK, Peterson CB, Moreno AC, Goepfert RP, Johnson FM, et al. Swallowing after primary TORS and unilateral or bilateral radiation for low- to intermediate-risk tonsil cancer. Otolaryngol Head Neck Surg. 2022;167(3):484\u201393.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"3896_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ijrobp.2007.12.033","volume":"72","author":"CA Murdoch-Kinch","year":"2008","unstructured":"Murdoch-Kinch CA, Kim HM, Vineberg KA, Ship JA, Eisbruch A. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72(2):373\u201382.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03896-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03896-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03896-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:54:24Z","timestamp":1781618064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03896-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3896"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03896-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki and was approved by The University of Texas MD Anderson Cancer Center Institutional Review Board for HN IMRT protocol PA2014-0194. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2165"}}